Brad L. Tade serves as Executive at ADMA BIOLOGICS, INC., where they oversee executive responsibilities. Since joining the company, Brad L. Tade has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2026 involved selling 6,479 shares valued at $105.7K.
Brad L. Tade currently holds 232,940 shares of ADMA BIOLOGICS, INC. (ADMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brad L. Tade has been a net neutral trader of ADMA stock. They have purchased $0 and sold $0 worth of shares.
Brad L. Tade's most recent insider trade was on Feb 19, 2026, when they sold 6,479 shares at $16.32 per share.
Get notified when new Form 4 filings are submitted
| $17.31 |
| Discretionary |
| Jul 24, 2024 | ADMA | $0 | Award | 72,400 | $N/A | Discretionary |